$BLRX

$2.03 +$0.02 (1.0%) Close

$BLRX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 2.61B shares outstanding

Who owns BLRX?

By type of holder

Institutions 0.0% Insiders 0.0% Everyone else 100.0%

Concentration Top 10 holders own 0.0%

Renaissance Technologies LLC 0.0% · Citadel Advisors LLC 0.0%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

+16.1K

by institutions in Q2 2026

New / sold out

3 / 3

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Renaissance Technologies LLC NEW +15.4K
Citadel Advisors LLC NEW +14.8K

Biggest sellers in Q2 2026

XTX Topco Ltd SOLD OUT −10.9K
Citigroup Inc −1.7K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for BioLine RX Ltd in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for BioLine RX Ltd.

How patient are the owners?

Institutional shares by how long they've been held

5+ years6% 3–5 years8% 1–3 years0% Under 1 year86%

Quarterly turnover

115.1%

of institutional shares changed hands

Top 10 managers, median time held

1 year

Super Investors

Investment managers reporting BLRX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
RT Renaissance Technologies LLC	15.4K	0.00%	NEW	Q2 '26	0.0%
Shares held by quarter Peak holding15.4K (Q2'26) Change over 8 quarters+15.4K Share of the company0.000% Renaissance Technologies LLC's full portfolio →
CA Citadel Advisors LLC	14.8K	0.00%	NEW	Q2 '26	0.0%
Shares held by quarter Peak holding36.7K (Q4'25) Change over 8 quarters+14.8K Share of the company0.000% Citadel Advisors LLC's full portfolio →

Renaissance Technologies LLC

15.4K

% of company

0.00%

Change vs last qtr

NEW

Held since

Q2 '26

Citadel Advisors LLC

14.8K

% of company

0.00%

Change vs last qtr

NEW

Held since

Q2 '26

14 more super investors behind a free account

See every manager holding BioLine RX Ltd, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting BLRX on Form N-PORT; together they hold 0.0% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
BA Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	$-1.13K	—	0.00%	0.00%	September 30, 2025

Blackstone Alternative Multi-Strategy Fund

Blackstone Alternative Investment Funds

Position value

$-1.13K

% of company

0.00%

% of the fund

0.00%

As of

September 30, 2025

Comments